Ignite Creation Date:
2025-12-24 @ 2:14 PM
Ignite Modification Date:
2026-02-05 @ 12:03 PM
Study NCT ID:
NCT05566795
Status:
RECRUITING
Last Update Posted:
2025-11-06
First Post:
2022-09-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2)
Sponsor:
Day One Biopharmaceuticals, Inc.
Organization:
Conditions & Keywords Data
Conditions: